OBI Pharma, Inc. (4174)
Market Closed
30 Jul, 05:30
TWSE 
JPX Primary TWSE NT$
24. 90
-0.65
-2.544%
NT$
- Market Cap
- P/E Ratio
32% Div Yield
213,368 Volume
- Eps
NT$ 25.55
Previous Close Want to track 4174 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
OBI Pharma, Inc. (4174) Statistics
Valuation metrics
Market Cap -
Enterprise value 3.69B
Trailing P/E (ttm) -0.9
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 72.97
Price/Book (mrq) 2.47
Enterprise Value/Revenue 74.33
Enterprise Value/EBITDA -1.99
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 280.3K
Average volume (90 days) 546.26K
Price summary
52-Week low 24.7
52-Week high 73.2
Beta -
50-Day moving average 28.66
200-Day moving average 37.12
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 30 Jul 2026
Ex-Dividend Date 30 Jul 2026
Last split factor 500:1,000
Last split Date 27 Jan 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -39.89%
Operating margin -42.45%
Operational effectiveness
Return on assets -0.69%
Return on equity -0.97%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.38
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -15.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.1
Total debt (mrq) -
Total Debt/Equity (mrq) 0.32
Current ratio (mrq) 3.44%
Book value per share (mrq) 17.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
